Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 41

    Aleor Derma Karakhadi unit clears USFDA inspection

    Aleor Derma Karakhadi unit clears USFDA inspection

    Medical Dialogues Bureau9 Jan 2020 1:33 PM IST
    Mumbai: Drugmaker Alembic Pharma recently informed the bourses that its Joint Venture, Aleor Dermaceutical has successfully completed the US drug...
    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Medical Dialogues Bureau9 Jan 2020 9:30 AM IST
    Until joining Strides Pharma, Dr R Ananthanarayanan was the Global Chief Operating Officer at Cipla Limited.Bangalore: Strides Pharma Science Limited...
    Novartis acquires The Medicines Company, adds cholesterol-lowering therapy inclisiran

    Novartis acquires The Medicines Company, adds cholesterol-lowering therapy inclisiran

    Medical Dialogues Bureau9 Jan 2020 9:22 AM IST
    New Delhi: Novartis AG (Novartis) recently announced that it has completed the acquisition of The Medicines Company (the “Company”) through the...
    Esteve to buy German pharma firm Riemser from Ardian

    Esteve to buy German pharma firm Riemser from Ardian

    Medical Dialogues Bureau9 Jan 2020 9:00 AM IST
    Riemser specialises in oncology, neurology, and infectiology and had since 2012 been part of Ardian's portfolio. Ardian in 2018 unsuccessfully tried...
    Arena Pharma CEO Targets Brain Diseases as Next Drug Frontier- Bloomberg Report

    Arena Pharma CEO Targets Brain Diseases as Next Drug Frontier- Bloomberg Report

    Medical Dialogues Bureau8 Jan 2020 2:10 PM IST
    Arena Pharmaceuticals Inc. shares have nearly tripled since Chief Executive Amit Munshi took the helm in 2016 and now he’s setting a new course as the...
    Daiichi Sankyo introduces Enhertu - breast cancer drug in US

    Daiichi Sankyo introduces Enhertu - breast cancer drug in US

    Medical Dialogues Bureau8 Jan 2020 2:08 PM IST
    Tokyo and Basking Ridge, NJ – Daiichi Sankyo announced that ENHERTU® (fam-trastuzumab deruxtecan-nxki), a HER2 directed antibody-drug conjugate, is...
    Keytruda plus chemotherapy results in statistically significant improvement in PFS compared to chemotherapy alone

    Keytruda plus chemotherapy results in statistically significant improvement in PFS compared to chemotherapy alone

    Medical Dialogues Bureau8 Jan 2020 2:05 PM IST
    NJ- Merck has announced that the Phase 3 KEYNOTE-604 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met...
    Antiepileptic drug Lamotrigine will have to carry warning for hemophagocytic lymphohistiocytosis: CDSCO

    Antiepileptic drug Lamotrigine will have to carry warning for hemophagocytic lymphohistiocytosis: CDSCO

    Medical Dialogues Bureau8 Jan 2020 11:42 AM IST
    New Delhi: Commonly used bipolar disorder and epilepsy bipolar drug Lamotrigine will have to now carry mandatory safety alert in its leaflet regarding...
    Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

    Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

    Medical Dialogues Bureau7 Jan 2020 3:26 PM IST
    In addition to the investment, Everstone Managing Directors Arjun Oberoi and Puncham Mukim will join Slayback Pharma's Board of Directors. Everstone...
    DCGI to conduct Special Public Hearing every month; Details

    DCGI to conduct Special Public Hearing every month; Details

    Farhat Nasim7 Jan 2020 2:15 PM IST
    As per the order, a special hearing will be conducted at the DCGI Office every month. Every second and the fourth Wednesday, from 3 in the evening has...
    Glenmark gets USFDA nod for Deferasirox tablets to treat high levels of iron

    Glenmark gets USFDA nod for Deferasirox tablets to treat high levels of iron

    Farhat Nasim7 Jan 2020 11:55 AM IST
    "Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for...
    AstraZeneca Lokelma gets Chinese approval for treating hyperkalaemia

    AstraZeneca Lokelma gets Chinese approval for treating hyperkalaemia

    Medical Dialogues Bureau7 Jan 2020 9:30 AM IST
    New Delhi: AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of adult patients with hyperkalaemia...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok